Literature DB >> 7760517

Effect of the angiotensin-converting enzyme inhibitor alacepril on ventricular function and beta-adrenoceptor number in rabbits with aortic regurgitation.

T Yoshikawa1, S Handa, K Nagami, M Suzuki, Y Wainai, T Minami, K Suzuki, S Kitazawa.   

Abstract

This study was performed to determine the effects of the angiotensin-converting enzyme inhibitor alacepril on hemodynamic variables and beta-adrenoceptor number in rabbits with heart failure induced by aortic regurgitation. Aortic regurgitation was induced by perforation of the aortic valve in 12 rabbits. Sixty mg/kg of alacepril was administered by gastric tube for 7 days after manifestation of aortic regurgitation to 6 rabbits (group AR + A). The other 6 rabbits with aortic regurgitation were administered vehicle in the same fashion (group AR + C). Seven rabbits underwent sham operation (group S). One week after induction of aortic regurgitation left ventricular end-diastolic pressure was higher and cardiac output was lower in AR + C than in S. End-diastolic and end-systolic left ventricular diameter were larger and left ventricular weight was also higher in AR + C than in S. For each of these parameters, the opposite findings were obtained from a comparison of AR + A and S. Myocardial beta-adrenoceptor density and norepinephrine content were reduced in AR + C, but were restored in AR + A. These findings indicate that alacepril has beneficial effects on ventricular remodeling and function, and on sympatho-neuronal regulation in the volume-overloaded myocardium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7760517     DOI: 10.1536/ihj.36.91

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  2 in total

1.  Effects of methylprednisolone on hemodynamics and beta-adrenergic receptor signaling in rabbits with acute left ventricular failure.

Authors:  H Nishimura; T Yoshikawa; N Kobayashi; T Anzai; K Nagami; S Handa; S Ogawa
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

2.  Effects of the angiotensin-converting enzyme inhibitor alacepril in dogs with mitral valve disease.

Authors:  Yasutomo Hori; Kensuke Nakamura; Nobuyuki Kanno; Makoto Hitomi; Yohei Yamashita; Satoshi Hosaka; Noriko Isayama; Takahiro Mimura
Journal:  J Vet Med Sci       Date:  2018-06-22       Impact factor: 1.267

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.